BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11156084)

  • 1. Neopterin: a prognostic variable in operations for lung cancer.
    Prommegger R; Widner B; Murr C; Unger A; Fuchs D; Salzer GM
    Ann Thorac Surg; 2000 Dec; 70(6):1861-4. PubMed ID: 11156084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer.
    Yamamoto K; Ohsumi A; Kojima F; Imanishi N; Matsuoka K; Ueda M; Miyamoto Y
    Ann Thorac Surg; 2010 Feb; 89(2):353-9. PubMed ID: 20103297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical lung cancer resection? A clinical observation pro and contra].
    Weber J
    Zentralbl Chir; 1990; 115(1):35-42. PubMed ID: 2156393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of urinary neopterin in patients with lung cancer.
    Kronberger P; Weiss G; Tschmelitsch J; Fuchs D; Salzer GM; Wachter H; Reibnegger G
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):831-7. PubMed ID: 8620060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
    Chabowski M; Orłowski TM; Rabczenko D
    Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
    Hoang JK; Patz E; Giroux D; Goldstraw P
    J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
    Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends and survival after surgery for p-stage IIIa, pN2 non-small cell lung cancer (NSCLC).
    Tanaka F; Yanagihara K; Ohtake Y; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1997 Sep; 12(3):372-9. PubMed ID: 9332914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
    Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
    Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer.
    Rea F; Loy M; Bortolotti L; Feltracco P; Fiore D; Sartori F
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):201-5. PubMed ID: 9080142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of surgery for lung cancer in young and elderly patients.
    Yazgan S; Gürsoy S; Yaldiz S; Basok O
    Surg Today; 2005; 35(10):823-7. PubMed ID: 16175462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following resection of clinically occult N2 non small cell lung cancer.
    Dalton R; Keller S
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invited commentary.
    Burfeind W
    Ann Thorac Surg; 2010 Feb; 89(2):359. PubMed ID: 20103298
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.
    Sok M; Ravnik J; Ravnik M
    Wien Klin Wochenschr; 2009; 121(9-10):314-7. PubMed ID: 19562293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.